Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Edimar, Bocchi"'
Autor:
Dennis M. McNamara, Leslie T. Cooper, Yaron Arbel, Arvind Bhimaraj, Edimar Bocchi, Matthias G. Friedrich, Matthieu Kerneis, Peter Liu, Andrea B. Parker, Eldon R. Smith, W. H. Wilson Tang, Guillermo Torre‐Amione, Carsten Tschöpe, ARCHER Study Group
Publikováno v:
ESC Heart Failure, Vol 11, Iss 5, Pp 3416-3424 (2024)
Abstract Aims Acute myocarditis, although a rare disease, can be associated with sudden cardiac death or the need for transplantation in both children and young adults. To date, there is no definitive evidence to support the routine use of immunosupp
Externí odkaz:
https://doaj.org/article/31deb9cc7adf4749a23a3d02a5ba63f7
Autor:
Filippe Barcellos Filippini, Henrique Barbosa Ribeiro, Edimar Bocchi, Fernando Bacal, Fabiana G. Marcondes-Braga, Monica S. Avila, Janine Daiana Sturmer, Mauricio Felippi de Sá Marchi, Gabriel Kanhouche, Antônio Fernando Freire, Renata Cassar, Alexandre A. Abizaid, Fábio Sândoli de Brito Jr
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 120, Iss 11 (2023)
Resumo As inovações em dispositivos ao longo das últimas décadas proporcionaram uma melhora no diagnóstico e tratamento de pacientes com insuficiência cardíaca. Essas novas ferramentas progressivamente adaptaram-se a estratégias minimamente i
Externí odkaz:
https://doaj.org/article/c833346453154c80aacfb548c673cef9
Autor:
Alexandra Gomes dos Santos, Elieser Hitoshi Watanabe, Daiane Tomomi Ferreira, Jamille Oliveira, Érika Shimoda Nakanishi, Claudia Silva Oliveira, Edimar Bocchi, Cristina Terra Gallafrio Novaes, Fatima Cruz, Noemia Barbosa Carvalho, Paula Keiko Sato, Edite Hatsumi Yamashiro-Kanashiro, Alessandra Pontillo, Vera Lucia Teixeira de Freitas, Luiz Fernando Onuchic, Maria Aparecida Shikanai-Yasuda
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
BackgroundChagas disease caused by Trypanosoma cruzi (T. cruzi) affects approximately six million individuals worldwide. Clinical manifestations are expected to occur due to the parasite persistence and host immune response. Herein we investigated po
Externí odkaz:
https://doaj.org/article/d8303e916d0b47bfa459a7ee29ba5ecf
Autor:
Javed Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, João Pedro Ferreira, Martina Brueckmann, Edimar Bocchi, Michael Böhm, Vijay K. Chopra, Nadia Giannetti, Tomoko Iwata, James L. Januzzi, Sanjay Kaul, Ileana L. Piña, Piotr Ponikowski, Ursula Rauch-Kröhnert, Sanjiv J. Shah, Michele Senni, Mikhail Sumin, Subodh Verma, Jian Zhang, Stuart J. Pocock, Faiez Zannad, Milton Packer, Stefan D. Anker
Publikováno v:
Circulation
Circulation, 2022, 146 (14), pp.1046-1055. ⟨10.1161/CIRCULATIONAHA.122.059755⟩
Circulation, 2022, 146 (14), pp.1046-1055. ⟨10.1161/CIRCULATIONAHA.122.059755⟩
Background: Women and men with heart failure (HF) and preserved ejection fraction may differ in their clinical characteristics and their response to therapy. The aim of this study was to evaluate the influence of sex on the effects of empagliflozin i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::208cf0a3de240b1774e143c79ead906b
https://pubmed.ncbi.nlm.nih.gov/36098051
https://pubmed.ncbi.nlm.nih.gov/36098051
Autor:
Maria de Lourdes Higuchi, Joyce Kawakami, Renata Ikegami, Maysa Beatriz Mandetta Clementino, Flavio M Kawamoto, Marcia M Reis, Edimar Bocchi
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 104, Pp 199-207 (2009)
Chronic cardiopathy (CC) in Chagas disease is a fibrotic myocarditis with C5b-9 complement deposition. Mycoplasma and Chlamydia may interfere with the complement response. Proteolytic enzymes and archaeal genes that have been described in Trypanosoma
Externí odkaz:
https://doaj.org/article/714ac17ee1a14c22b9c9f00aa2bc24d3
Autor:
Stefan D. Anker, Javed Butler, Muhammad Shariq Usman, Gerasimos Filippatos, João Pedro Ferreira, Edimar Bocchi, Michael Böhm, Hans Pieter Brunner-La Rocca, Dong-Ju Choi, Vijay Chopra, Eduardo Chuquiure, Nadia Giannetti, Juan Esteban Gomez-Mesa, Stefan Janssens, James L. Januzzi, José R. González-Juanatey, Bela Merkely, Stephen J. Nicholls, Sergio V. Perrone, Ileana L. Piña, Piotr Ponikowski, Michele Senni, David Sim, Jindrich Spinar, Iain Squire, Stefano Taddei, Hiroyuki Tsutsui, Subodh Verma, Dragos Vinereanu, Jian Zhang, Tomoko Iwata, Janet M. Schnee, Martina Brueckmann, Stuart J. Pocock, Faiez Zannad
Publikováno v:
Nature Medicine, 28(12). Nature Publishing Group
The EMPEROR-Preserved trial showed that the sodium–glucose co-transporter 2 inhibitor empagliflozin significantly reduces the risk of cardiovascular death or hospitalization for heart failure (HHF) in heart failure patients with left ventricular ej
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de75b30aedf584479e878bb8eff3dcb9
https://cris.maastrichtuniversity.nl/en/publications/cf5df42c-b01e-4507-8922-a1da5d8fdf68
https://cris.maastrichtuniversity.nl/en/publications/cf5df42c-b01e-4507-8922-a1da5d8fdf68
Autor:
Bela Merkely, Nikolaus Marx, Subodh Verma, Michele Senni, Eduardo Chuquiure-Valenzuela, James L. Januzzi, Vijay K. Chopra, Dong-Ju Choi, Stefan D. Anker, Stefano Taddei, Ileana L. Piña, Juan Esteban Gomez-Mesa, Jose R Gonzalez-Juanatey, Dragos Vinereanu, Sergio V. Perrone, Faiez Zannad, Jian Zhang, Carolyn Su Ping Lam, Stuart J. Pocock, Stefan Janssens, Iain Squire, Waheed Jamal, Hans-Peter Brunner-La Rocca, Peter E. Carson, Javed Butler, David K.L. Sim, EMPEROR-Preserved Trial Investigators, Stephen J. Nicholls, Hiroyuki Tsutsui, Janet Schnee, Martina Brueckmann, João Pedro Ferreira, Piotr Ponikowski, Naveed Sattar, Gerasimos Filippatos, Sven Schnaidt, Edimar Bocchi, Michael Böhm, Jindrich Spinar, Cordula Zeller, Nadia Giannetti, Milton Packer
Publikováno v:
The New England Journal of Medicine, 385, 16, pp. 1451-1461
New England Journal of Medicine, 385(16), 1451-1461. MASSACHUSETTS MEDICAL SOCIETY
N. Engl. J. Med. 385, 1451-1461 (2021)
The New England Journal of Medicine, 385, 1451-1461
New England Journal of Medicine, 385(16), 1451-1461. MASSACHUSETTS MEDICAL SOCIETY
N. Engl. J. Med. 385, 1451-1461 (2021)
The New England Journal of Medicine, 385, 1451-1461
Item does not contain fulltext BACKGROUND: Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ef0d16771035c4e1ad15d0feed20fd3
http://hdl.handle.net/10281/373399
http://hdl.handle.net/10281/373399
Autor:
Fernando Bacal, Luis Fernando Seguro, Tania Ogawa, Sandrigo Mangini, Alfredo Fiorelli, Edimar Bocchi
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 93, Iss 6, Pp e104-e106 (2009)
O papel da resposta imunológica durante a infecção pelo vírus Influenza H1N1 não está totalmente estabelecido, mas acredita-se que atue de forma decisiva no agravamento do quadro e no aparecimento da síndrome de desconforto respiratório agudo
Externí odkaz:
https://doaj.org/article/df2b2b8f1a5c4f61ae1c140ab9b7e6a0
Autor:
Alexandra, Gomes Dos Santos, Elieser Hitoshi, Watanabe, Daiane Tomomi, Ferreira, Jamille, Oliveira, Érika Shimoda, Nakanishi, Claudia Silva, Oliveira, Edimar, Bocchi, Cristina Terra Gallafrio, Novaes, Fatima, Cruz, Noemia Barbosa, Carvalho, Paula Keiko, Sato, Edite Hatsumi, Yamashiro-Kanashiro, Alessandra, Pontillo, Vera Lucia Teixeira, de Freitas, Luiz Fernando, Onuchic, Maria Aparecida, Shikanai-Yasuda
Publikováno v:
Frontiers in Immunology
Background Chagas disease caused by Trypanosoma cruzi (T. cruzi) affects approximately six million individuals worldwide. Clinical manifestations are expected to occur due to the parasite persistence and host immune response. Herein we investigated p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6307e5bc0972cd03203a478b2b7d7f28
https://pubmed.ncbi.nlm.nih.gov/33193300
https://pubmed.ncbi.nlm.nih.gov/33193300
Autor:
Carolyn S P, Lam, Anna, Giczewska, Karen, Sliwa, Frank, Edelmann, Jens, Refsgaard, Edimar, Bocchi, Justin A, Ezekowitz, Adrian F, Hernandez, Christopher M, O'Connor, Lothar, Roessig, Mahesh J, Patel, Burkert, Pieske, Kevin J, Anstrom, Paul W, Armstrong, Shari, Cook
Publikováno v:
Lam, C S P, Giczewska, A, Sliwa, K, Edelmann, F, Refsgaard, J, Bocchi, E, Ezekowitz, J A, Hernandez, A F, O'Connor, C M, Roessig, L, Patel, M J, Pieske, B, Anstrom, K J, Armstrong, P W & VICTORIA Study Group 2021, ' Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event : Insights From the VICTORIA Trial ', JAMA cardiology, vol. 6, no. 6, pp. 706-712 . https://doi.org/10.1001/jamacardio.2020.6455
JAMA Cardiol
JAMA Cardiol
Importance: The period following heart failure hospitalization (HFH) is a vulnerable time with high rates of death or recurrent HFH.Objective: To evaluate clinical characteristics, outcomes, and treatment response to vericiguat according to prespecif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4273aa570e29339fc6fe0ead57ebeb37
https://doi.org/10.1001/jamacardio.2020.6455
https://doi.org/10.1001/jamacardio.2020.6455